Polyclonal Rabbit BAGE2 Antibody
- Known as:
- Polyclonal Rabbit BAGE2 Antibody
- Catalog number:
- KA0375
- Product Quantity:
- 100ul
- Category:
- -
- Supplier:
- KareBay
- Gene target:
- Polyclonal Rabbit BAGE2 Antibody
Ask about this productRelated genes to: Polyclonal Rabbit BAGE2 Antibody
- Gene:
- BAGE2 NIH gene
- Name:
- BAGE family member 2
- Previous symbol:
- -
- Synonyms:
- CT2.2
- Chromosome:
- 21p11.2
- Locus Type:
- unknown
- Date approved:
- 2001-06-01
- Date modifiied:
- 2017-02-24
Related products to: Polyclonal Rabbit BAGE2 Antibody
Related articles to: Polyclonal Rabbit BAGE2 Antibody
- Sepsis is a complex, life-threatening clinical syndrome that can cause other related diseases, such as acute kidney injury (AKI). Circular RNA (circRNA) is a type of non-coding RNA with a diverse range of functions, and it plays essential roles in miRNA sponge. CircRNA plays a huge part in the development of various diseases. CircRNA and the competing endogenous RNA (ceRNA) regulatory network are unknown factors in the onset and progression of septic AKI (SAKI). This study aimed to clarify the complex circRNA-associated regulatory mechanism of circRNAs in SAKI. We collected 40 samples of whole blood of adults, including 20 cases of SAKI and 20 cases of healthy controls. Moreover, five cases were each analyzed by RNA sequencing, and we identified differentially expressed circRNA, miRNA, and mRNA (DEcircRNAs, DEmiRNAs, and DEmRNAs, respectively). All samples were from SAKI patients with intraperitoneal infection. As a result, we screened out 236 DEcircRNAs, 105 DEmiRNAs, and 4065 DEmRNAs. Then, we constructed two co-expression networks based on RNA-RNA interaction, including circRNA-miRNA and miRNA-mRNA co-expression networks. We finally created a circRNA-miRNA-mRNA regulation network by combining the two co-expression networks. Functional and pathway analyses indicated that DEmRNAs in ceRNA were mostly concentrated in T cell activation, neutrophils and their responses, and cytokines. The protein-protein interaction network was established to screen out the key genes participating in the regulatory network of SAKI. The hub genes identified as the top 10 nodes included the following: ZNF727, MDFIC, IFITM2, FOXD4L6, CIITA, KCNE1B, BAGE2, PPIAL4A, USP17L7, and PRSS2. To our knowledge, this research is the first study to describe changes in the expression profiles of circRNAs, miRNAs, and mRNAs in patients with SAKI. These findings provide a new treatment target for SAKI treatment and novel ideas for its pathogenesis. - Source: PubMed
Publication date: 2023/09/14
Ma Si-RongMa QiMa Ya-NanZhou Wen-Jie - It is thought that cancer/testis antigens (CTAs) are expressed in a cascade-like manner in multiple myeloma as the disease progresses. In this pilot study, we investigated the co-expression of several CTAs in the peripheral blood (PB) during patient therapy to establish whether monitoring multiple CTAs allows for the prediction of relapse and clonal evolution. - Source: PubMed
Shires KarenWyk Teagan VanWienand Kirsty - Once considered nonfunctional, pseudogene transcripts are now known to provide valuable information for cancer susceptibility, including head and neck cancer (HNC), a serious health problem worldwide, with about 50% unimproved overall survival over the last decades. The present review focuses on the role of pseudogene transcripts involved in HNC risk and prognosis. We combined current literature and analyses from The Cancer Genome Atlas (TCGA) database to identify the most deregulated pseudogene transcripts in HNC and their genetic variations. We then built a co-expression network and performed gene ontology enrichment analysis to better understand the pseudogenes' interactions and pathways in HNC. In the literature, few pseudogenes have been studied in HNC. Our analysis identified 370 pseudogene transcripts associated with HNC, where , , , , , , , , and were found to be the most deregulated and presented several genetic alterations. , , and pseudogenes were predicted to interact with 12 genes known to participate in HNC, was predicted to interact with the gene, and pseudogene was predicted to interact with and genes. The identified pseudogenes were associated with cancer biology pathways involving cell communication, response to stress, cell death, regulation of the immune system, regulation of gene expression, and Wnt signaling. Finally, we assessed the prognostic values of the pseudogenes with the Kaplan-Meier Plotter database, and found that expression of , , , , and pseudogenes were associated with patients' survival. Due to pseudogene transcripts' potential for cancer diagnosis, progression, and as therapeutic targets, our study can guide new research to HNC understanding and development of new target therapies. - Source: PubMed
Publication date: 2021/08/17
Carron JulianaDella Coletta RafaelLourenço Gustavo Jacob - Because of the low thermal conductivity and high electrical conductivity, type-III Ba24Ge100 clathrates are potentially of interest as power generation thermoelectric materials for midto-high temperature operations. Unfortunately, their too high intrinsic carrier concentration results in a quite low Seebeck coefficient. To reduce the carrier concentration, we prepared a series of Ga/Ag codoped type-III Ba24Ge100 clathrate specimens by vacuum melting and subsequently compacted by spark plasma sintering (SPS). Doping Ga-Ag on the sites of Ge reduces the concentration of electrons and, at higher concentrations, also leads to the in situ formation of BaGe2 nanoprecipitates detected by the microstructural analysis. As a result of doping, the Seebeck coefficient increases, the thermal conductivity decreases, and the dimensionless figure of merit ZT reaches a value of 0.34 at 873 K, more than three times the value obtained with undoped Ba24Ge100. - Source: PubMed
Publication date: 2015/08/20
Fu JiefeiSu XianliZheng YunXie HongyaoYan YonggaoTang XinfengUher Ctirad - Cancer/testis (CT) antigens encoded by CT genes are immunogenic antigens, and the expression of CT gene is strictly restricted to only the testis among mature organs. Therefore, CT antigens are promising candidates for cancer immunotherapy. In a previous study, we identified a novel CT antigen, DNAJB8. DNAJB8 was found to be preferentially expressed in cancer stem-like cells (CSCs)/cancer-initiating cells (CICs), and it is thus a novel CSC antigen. In this study, we hypothesized that CT genes are preferentially expressed in CSCs/CICs rather than in non-CSCs/-CICs and we examined the expression of CT genes in CSCs/CICs. The expression of 74 CT genes was evaluated in side population (SP) cells (=CSC) and main population (MP) cells (=non-CSC) derived from LHK2 lung adenocarcinoma cells, SW480 colon adenocarcinoma cells and MCF7 breast adenocarcinoma cells by RT-PCR and real-time PCR. Eighteen genes (MAGEA2, MAGEA3, MAGEA4, MAGEA6, MAGEA12, MAGEB2, GAGE1, GAGE8, SPANXA1, SPANXB1, SPANXC, XAGE2, SPA17, BORIS, PLU-1, SGY-1, TEX15 and CT45A1) showed higher expression levels in SP cells than in MP cells, whereas 10 genes (BAGE1, BAGE2, BAGE4, BAGE5, XAGE1, LIP1, D40, HCA661, TDRD1 and TPTE) showed similar expression levels in SP cells and MP cells. Thus, considerable numbers of CT genes showed preferential expression in CSCs/CICs. We therefore propose a novel sub-category of CT genes in this report: cancer/testis/stem (CTS) genes. - Source: PubMed
Publication date: 2013/04/11
Yamada RTakahashi ATorigoe TMorita RTamura YTsukahara TKanaseki TKubo TWatarai KKondo THirohashi YSato N